Cite
HARVARD Citation
Ciccarese, M. et al. (2020). A multicenter phase II trial of nab‐paclitaxel and capecitabine in HER‐2 negative and triple‐ negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease?. Breast journal. 26 (9), pp. 1857-1859. [Online].